Skip to main content
eScholarship
Open Access Publications from the University of California

Which non-phamacologic interventions are most effective at addressing chemotherapy related cognitive impairment (CRCI) in adolescent and young adult cancer survivors?

The data associated with this publication are not available for this reason: N/A
Abstract

It often presents during and after treatment with memory impairment, concentration deficits, and depression. 25.75% prevalence in adolescent and young adult (AYA) cancer survivors. It significantly impacts school, work, daily activities, and overall quality of life.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View